Platelet Adhesion and Activation in an ECMO Thrombosis‐on‐a‐Chip Model
Tiffany Goh,Lingzi Gao,Jasneil Singh,Richard Totaro,Ruaidhri Carey,Kevin Yang,Bruce Cartwright,Mark Dennis,Lining Arnold Ju,Anna Waterhouse
DOI: https://doi.org/10.1002/advs.202401524
IF: 15.1
2024-05-19
Advanced Science
Abstract:Based on clinical ECMO flow and thrombosis location, an ECMO thrombosis‐on‐a‐chip model is developed with customizable biomaterial and flow combinations, which uses low blood volumes. Real‐time microscopy revealed that low flow rates, deceleration, and stasis significantly increases acute platelet adhesion, and occlusion and embolism can be visualized. Increased platelet activation is observed on polyvinyl chloride compared to polycarbonate. Use of extracorporeal membrane oxygenation (ECMO) for cardiorespiratory failure remains complicated by blood clot formation (thrombosis), triggered by biomaterial surfaces and flow conditions. Thrombosis may result in ECMO circuit changes, cause red blood cell hemolysis, and thromboembolic events. Medical device thrombosis is potentiated by the interplay between biomaterial properties, hemodynamic flow conditions and patient pathology, however, the contribution and importance of these factors are poorly understood because many in vitro models lack the capability to customize material and flow conditions to investigate thrombosis under clinically relevant medical device conditions. Therefore, an ECMO thrombosis‐on‐a‐chip model is developed that enables highly customizable biomaterial and flow combinations to evaluate ECMO thrombosis in real‐time with low blood volume. It is observed that low flow rates, decelerating conditions, and flow stasis significantly increased platelet adhesion, correlating with clinical thrombus formation. For the first time, it is found that tubing material, polyvinyl chloride, caused increased platelet P‐selectin activation compared to connector material, polycarbonate. This ECMO thrombosis‐on‐a‐chip model can be used to guide ECMO operation, inform medical device design, investigate embolism, occlusion and platelet activation mechanisms, and develop anti‐thrombotic biomaterials to ultimately reduce medical device thrombosis, anti‐thrombotic drug use and therefore bleeding complications, leading to safer blood‐contacting medical devices.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry